Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lemon Bottle is a lipolytic injectable solution developed for aesthetic body contouring and the reduction of localized subcutaneous fat. Unlike many traditional fat-dissolving products that utilize deoxycholic acid, Lemon Bottle is formulated with a high concentration of Riboflavin (Vitamin B2), Lecithin, and Bromelain. Riboflavin serves to accelerate fat metabolism, Lecithin acts as an emulsifier to disrupt adipocyte membranes and facilitate fat transport, and Bromelain, a proteolytic enzyme derived from pineapples, assists in the breakdown of fat cells and helps manage post-injection inflammation. The product is administered via subcutaneous injection directly into fat deposits such as the submental area (double chin), abdomen, arms, or thighs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lemon Bottle.